Research article · 21 Jun 2013
Conference abstractPublished 27 Oct 2014
Formulation and evaluation of telmisartan fast dissolving tablets using liqui-solid technology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Telmisartan is an Angiotensin receptor blocker which comes under BCS class-2. Liquisolid technique is a novel approach for FDT. Formulation of drug includes API (Telmisartan) and excipients like binders, glidants, superdisintegrants, lubricants and non-volatile solvents. The main theme of formulation is to disintegrate the tablet within seconds. Evaluation is carried out by pre compression parameters and post compression parameters, solubility studies, bioavailability and bioequivalence studies, drug excipient compatibility studies, disintegration and dissolution parameters, wetting time, water absorption ratio. Analysis of drug using HPLC, IR and stability of drug is performed as per ICH guidelines. Comparison of formulation with conventional dosage forms which results in better drug release in pH 7.4 phosphate buffer.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 3 May 2019
Formulation Development and in vitro Evaluation of Sustained Release Tablets of Telmisartan by Solid Dispersion Technology
Research article · 31 Jul 2014
Formulation and Evaluation of Fast Dissolving Tablets of Diclofenac Sodium by Novel Hole Technology
Research article · 3 May 2016
Formulation development and evaluation of fast dissolving film of telmisartan
Research article · 9 Dec 2021
Improvement of Solubility and Dissolution by Liqui-Solid Compact
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sindhu Reddy Musipatla”

